ArticleInternational journal of clinical oncology2024

Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.

Atsuto Mouri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.